DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mirodenafil
Mirodenafil
Screening of Phosphodiesterase-5 Inhibitors and Their Analogs in Dietary Supplements by Liquid Chromatography–Hybrid Ion Trap–Time of Flight Mass Spectrometry
Call for Methods
2251 Adulteration of Dietary Supplements with Drugs
Phosphodiesterase (PDE)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Effects of the Combined Use of a PDE5 Inhibitor and Medications for Hypertension, Lower Urinary Tract Symptoms and Dyslipidemia on Corporal Tissue Tone
Illicit Erectile Dysfunction Products in the Netherlands Dysfunction a Decade of Trends and a 2007-2010 Product Update Products
Botanical Dietary Supplements Detecting Novel Designer Analogues Using MS-Based Approaches
Comparative Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction in Diabetic Men: a Bayesian Netw
Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: a Trade-Off Network Meta-Analysis
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: a Review Tiago Rocha, Joana S
Type of Posting Revision Bulletin Posting Date 27–May–2016 Official
The Penile Erection Efficacy of a New Phosphodiesterase Type 5 Inhibitor, Mirodenafil (SK3530), in Rabbits with Acute Spinal Cord Injury
Advances in Targeting Cyclic Nucleotide Phosphodiesterases
The Effect of Mirodenafil on the Penile Erection and Corpus Cavernosum in the Rat Model of Cavernosal Nerve Injury
(12) United States Patent (10) Patent No.: US 8,916,564 B2 Pettersson Et Al
Analysis of Erectile Dysfunction Drugs and Their Analogues in Counterfeit
Top View
INTIMACY with IMPOTENCE
Mirodenafil for the Treatment of Erectile Dysfunction: a Systematic Review of the Literature
Pharmaabkommen A1 E
Bioactive Compound Library Plus (96-Well)
Phosphodiesterase Inhibitors Say NO to Alzheimer's Disease
Efficacy and Safety of Tadalafil 5 Mg Administered Once Daily in Korean Men with Erectile Dysfunction: a Prospective, Multicenter Study
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Drug Repurposing Compound Library Plus (96-Well)
The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts
Working Group on PDE5 Inhibitors Chair, Katerina Mastovska Outline
A61k9/20 (2006.01) A61k9/28 (2006.01)
Chromatographic Separation and Identification of Sildenafil and Yohimbine Analogues Illegally Added in Herbal Supplements
Cgmp Signaling, Phosphodiesterases and Major Depressive Disorder
Drug Repurposing Compound Library (96-Well)
SMPR 2014 010.Indd
The Efficacy of Mirodenafil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Middle-Aged Males
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction
ISPOR Baltimore
Efficacy and Safety of PDE5 Inhibitors in the Treatment of Diabetes Mellitus Erectile Dysfunction
Visual Side Effects Linked to Sildenafil Consumption: an Update
WO 2015/054109 Al 16 April 2015 (16.04.2015) P O P C T